SENS Senseonics Holdings Inc gains 18% Feb 11, 2022

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.http://www.priceseries.com/trade/SENS-Senseonics-Holdings-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2022013120220211.html